Temocine 100mg Capsule

Temocine 100mg Capsule

Prescription requiredRx Required

Salt Composition: Temozolomide

Expiry Date: 01/2028

Special offer

Buy at $12,079.50

$12,079.50

Inclusive of all taxes

5 capsule

Fast Delivery
Easy Returns
Secure Payments

About The Product

Chemotherapy, Brain Cancer, Cancer Medicines

Temocine 100mg Capsule belongs to the category of anticancer medicines. These medicines are primarily used to treat patients diagnosed with brain cancer, malignant melanoma, blood cancer, breast cancer, non-small cell lung cancer, and ovarian cancer. The growth of cancer cells is uncontrollable and abnormal in the human body. It is difficult to diagnose cancer in the early stages. When diagnosed in advanced stages, only the symptoms of the disease can be reduced. Temocine Capsule is usually given in combination with another anticancer medicine as a part of combination therapy to increase the efficacy of the treatment.

i
Trust & safety

Medical Disclaimer

Accurate, reviewed information to support informed healthcare decisions

For informational purposes only
Not a substitute for professional medical advice
Consult your doctor for diagnosis and treatment

Magicine's primary objective is to ensure that its customers receive accurate, genuine, and trustworthy information reviewed by medical experts.

The content on this website has been produced solely for informational purposes. This is not intended to take the place of medical advice and care provided by a licensed professional, though.

This information may not include all potential side effects, warnings, and details about specific lab tests, medications, and medical conditions. Please ask your doctor any questions you may have about any drug or disease.

Our goal is not to replace or substitute for the doctor-patient relationship, but to uphold and strengthen it.

Always follow advice from your doctor, pharmacist, or other licensed healthcare professional before starting, stopping, or changing any medicine or treatment.
Magicine PharmacopyCopyright 2026